Device Trial Radar · NCT00196066
Evaluation of the Zilver Vascular Stent in the Iliac Arteries (ZIPS)
Last checked: Nov 20, 2026Latest source record: May 10, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
150
Actual
Start
Oct 2002
Primary completion
Not stated
Study completion Apr 2006
Sponsor
- Lead sponsor
- Cook Group IncorporatedNot on our public-company list
- Sponsor type
- Industry
- First posted
- Sep 20, 2005
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- Who can join
- All sexes, from 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the ability of a vascular stent to maintain an open iliac (leg) artery. The Zilver Vascular Stent is made of nitinol, a flexible metal with a long history of use in medical devices. The stent self-expands once inside the artery where it is intended to hold the vessel wall open. Within a few weeks, a layer of cells will grow over the stent helping to hold it in place.
Conditions
- Peripheral Arterial Disease (PAD)
Interventions
Peripheral Vessel StentingDevice
Primary outcomes
What the sponsor says the trial is designed to measure.
- The primary endpoint of the study is major adverse event (MAE) rate at the 9-month follow-up.
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.